Lobbying Information
Subject Matters
- Health
- Industry
- Intellectual Property
- International Trade
- Science and Technology
Subject matters added through a monthly communication report
- Justice and Law Enforcement
- Non-Insured Health Benefits (NIHB) Reimbursement Issues
Subject Matter Details
Legislative Proposal, Bill or Resolution
- Bill C6 Canada Consumer Product Safety Act, with regards to confidentiality provisions, penalty levels.
Policies or Program
- Health Canada's enforcement of Canada's Food and Drugs Act and Regulations as they relate to the cross border sale of drugs to the United States.
- Input to proposed changes to PMPRB Excessive Price Guidelines.
- The House of Commons Standing Committee on Health's (HESA) study of the Common Drug Review (CDR) with regard to progress accomplished on the recommendations.
Regulation
- An amendment to the Patented Medicines (Notice of Compliance) Regulations ("PM(NOC) Regulations") regarding the right to appeal.
- Health Canada's proposal to add the drug tramadol to the Schedule of the Narcotic Control Regulations (NCR).
Communication Techniques
-
Written communication
-
Oral communication
Government Institutions
-
Finance Canada (FIN)
-
Foreign Affairs and International Trade Canada (DFAITC)
-
Health Canada (HC)
-
Industry Canada
-
Members of the House of Commons
-
Patented Medicine Prices Review Board (PMPRB)
Government institutions added through a monthly communication report
In-house Corporation Details
Description of activities
Research based pharmaceutical company
Responsible officer name and position during the period of this registration
Chris Halyk,
General Manager
Government funding
No government funding was received during the last completed financial year.
In-house Corporation Contact Information
Address:
19 Green Belt Drive
Toronto, ON M3C 1L9
Canada
Telephone number:
416-449-9444
Fax number:
416-449-2658
Parent Company Information
- Johnson & Johnson
-
One Johnson & Johnson Plaza
New Brunswick, NJ 08933
United States of America
Subsidiary Beneficiary Information
Janssen Ortho Inc does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Lobbyists Details
Senior Officers whose lobbying activities represent less than 20% of their Duties
- Penny Albright,
Vice President (VP) Government & Health Economics |
No public offices held
- Fiona Dunbar,
VP World Wide Medical Affairs |
No public offices held
- Cathy Lau,
VP Regulatory Affairs |
No public offices held
- Veera Rastogi,
VP Law |
Public offices held
Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties
- Lesia Babiak,
Director, Federal Affairs & Health Policy |
No public offices held